Stay updated on Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Sign up to get notified when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.

Latest updates to the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page
- CheckyesterdayChange DetectedThe Record History now contains an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3, reflecting minor site version updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now includes Revision: v3.3.3; the HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded a new history entry for revision v3.3.2 and removed the v3.2.0 entry.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding/operating status notice that appeared on the page. The clinical trial record and study details remain unchanged.SummaryDifference0.7%

- Check73 days agoChange DetectedVersion history shows updates to the study's recruitment status and overall study status, with corresponding edits to contacts/locations. These updates reflect the current state of the clinical trial on the record.SummaryDifference0.1%

- Check101 days agoChange DetectedUpdated the page to announce v3.2.0 with a funding-related operating status notice, replacing the previous v3.1.0. Key impact: users are informed about potential service disruptions and where to verify status.SummaryDifference12%

Stay in the know with updates to Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lisdexamfetamine Effect/Safety in ADHD+Autism Ages 6-12 Clinical Trial page.